Heron Therapeuti Financials
| HRTX Stock | USD 2.40 0.05 2.04% |
Heron |
Understanding current and past Heron Therapeuti Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Heron Therapeuti's financial statements are interrelated, with each one affecting the others. For example, an increase in Heron Therapeuti's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Heron Therapeuti's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heron Therapeuti. Check Heron Therapeuti's Beneish M Score to see the likelihood of Heron Therapeuti's management manipulating its earnings.
Heron Therapeuti Stock Summary
Heron Therapeuti competes with Mereo BioPharma, Terns Pharmaceuticals, PDS Biotechnology, Inozyme Pharma, and Hookipa Pharma. Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Heron Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 302 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US4277461020 |
| CUSIP | 427746102 00202J203 00202J104 00754G102 |
| Location | California; U.S.A |
| Business Address | 100 Regency Forest |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.herontx.com |
| Phone | (858) 251 4400 |
| Currency | USD - US Dollar |
Heron Therapeuti Key Financial Ratios
| Return On Equity | -24.09 | ||||
| Return On Asset | -0.0316 | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 122 | ||||
| Beta | 1.55 |
Heron Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Heron Therapeuti's current stock value. Our valuation model uses many indicators to compare Heron Therapeuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heron Therapeuti competition to find correlations between indicators driving Heron Therapeuti's intrinsic value. More Info.Heron Therapeuti is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heron Therapeuti's earnings, one of the primary drivers of an investment's value.Heron Therapeuti Systematic Risk
Heron Therapeuti's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Heron Therapeuti volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Heron Therapeuti correlated with the market. If Beta is less than 0 Heron Therapeuti generally moves in the opposite direction as compared to the market. If Heron Therapeuti Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Heron Therapeuti is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Heron Therapeuti is generally in the same direction as the market. If Beta > 1 Heron Therapeuti moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Heron Therapeuti is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Heron has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Heron Therapeuti's financials are consistent with your investment objective using the following steps:- Review Heron Therapeuti's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Heron Therapeuti's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Heron Therapeuti's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Heron Therapeuti's stock is overvalued or undervalued.
Heron Therapeuti Thematic Clasifications
Heron Therapeuti is part of Cancer Fighters investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases
This theme covers Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. Get More Thematic Ideas
| Cancer Fighters | View |
Heron Therapeuti March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Heron Therapeuti help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Heron Therapeuti. We use our internally-developed statistical techniques to arrive at the intrinsic value of Heron Therapeuti based on widely used predictive technical indicators. In general, we focus on analyzing Heron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Heron Therapeuti's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.17 | |||
| Information Ratio | 0.1697 | |||
| Maximum Drawdown | 29.8 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 7.98 |
Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.